Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
2021 · Allergology International · 19 citations
https://doi.org/10.1016/j.alit.2021.01.001
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
606
Citations
12
h-index
14
i10-index
Makoto Nagasaki is an academic researcher from Shimane Prefectural Central Hospital. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & T-cell and B-cell Immunology & Asthma and respiratory diseases. The author has an h-index of 12, co-authored 48 publications.
https://doi.org/10.1016/j.alit.2021.01.001
https://doi.org/10.7759/cureus.36932
Click to start Chat